Zobrazeno 1 - 10 of 124 pro vyhledávání: '"E. van den Eynde"'
1
Akademický článek
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
Autor: Rubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, Juan González-García, Oscar Brochado-Kith, Amanda Fernández-Rodríguez, Cristina Díez, Victor Hontañon, The Marathon Study Group, Salvador Resino, María Ángeles Jiménez-Sousa, A. Arranz, F. Arnalich, J. R. Arribas, E. Aznar, T. Aldamiz-Echevarría, J. Bermejo, J. Berenguer, J. M. Bellón, I. Bernardino, M. J. Bustinduy, A. Carrero, S. Carretero, E. Casas, J. L. Casado, M. Crespo, P. Crespo, C. Díez, M. Díaz, J. de Miguel, F. Dronda, H. Esteban, C. Fanciulli, A. Ferrer, M. J. Galindo, J. González-García, I. Gutiérrez, A. Iribarren, V. Hontañón, C. López, P. Miralles, M. L. Montes, A. Moreno, S. Moreno, L. Ortiz, E. Ortega, B Padilla, J. F. Parras, L. Pérez-Latorre, F. Pascual, M. Pérez, M. J. Pérez-Elías, J. M. Peña, C. Quereda, M. Ramírez, E. Ribera, J. F. Rodríguez-Arrondo, J. Sanz, I. Santos, M. A. Sanfrutos, S. Schroeder, F. Tejerina, M. J. Téllez, E. Van den Eynde, J. Vergas, M. A. Von-Wichmann, M. Yllescas, J. F. Zamora
Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)
BackgroundUnderstanding the predictors of metabolic disorders in persons with HIV/HCV coinfection post-HCV therapy is crucial for improving patient outcomes. Since immune checkpoint proteins are usually upregulated in these persons with HIV/HCV coinf
Externí odkaz: https://doaj.org/article/172bda063f904417a50997f3f3bc0faf
Zobrazit plný text záznamu
2
Akademický článek
Scoping literature review and focus groups with healthcare professionals on psychosocial and lifestyle assessments for childhood obesity care
Autor: L. W. Koetsier, E. van den Eynde, E. G. A. H. van Mil, M. van der Velde, R. de Vries, C. A. Baan, J. C. Seidell, J. Halberstadt
Publikováno v: BMC Health Services Research, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background Childhood obesity is a complex disease resulting from the interaction of multiple factors. The effective management of childhood obesity requires assessing the psychosocial and lifestyle factors that may play a role in the develop
Externí odkaz: https://doaj.org/article/4361959b8d7e4a59b71787be505d0013
Zobrazit plný text záznamu
3
Akademický článek
Conducting a psychosocial and lifestyle assessment as part of an integrated care approach for childhood obesity: experiences, needs and wishes of Dutch healthcare professionals
Autor: L. W. Koetsier, M. M. A. van Mil, M. M. A. Eilander, E. van den Eynde, C. A. Baan, J. C. Seidell, J. Halberstadt
Publikováno v: BMC Health Services Research, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The causes and consequences of childhood obesity are complex and multifaceted. Therefore, an integrated care approach is required to address weight-related issues and improve children’s health, societal participation and quality
Externí odkaz: https://doaj.org/article/dedd138ef8514fb4bb398b13c256b2b9
Zobrazit plný text záznamu
4
Akademický článek
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study
Autor: M. Laguno, M.A. Von Wichmann, E. Van den Eynde, J. Navarro, C. Cifuentes, J. Murillas, S. Veloso, M. Martínez-Rebollar, J.M. Guardiola, A. Jou, J.L. Gómez-Sirvent, M. Cervantes, J.A. Pineda, S. López-Calvo, A. Carrero, M.L. Montes, E. Deig, A. Tapiz, J.D. Ruiz-Mesa, A. Cruceta, E. de Lazzari, J. Mallolas
Publikováno v: International Journal of Infectious Diseases, Vol 53, Iss C, Pp 46-51 (2016)
Introduction: Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of BOC + pegylated interferon-α2a/ribavirin (PEG-IFN/RBV) in the retreatment of
Externí odkaz: https://doaj.org/article/05b17d5d28db44e8ba709ee912443059
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Conducting a psychosocial and lifestyle assessment as part of an integrated care approach for childhood obesity: experiences, needs and wishes of Dutch healthcare professionals
Autor: M. M. A. van Mil, L. W. Koetsier, Jutka Halberstadt, E. van den Eynde, Caroline A Baan, Jacob C. Seidell, M. M. A. Eilander
Publikováno v: BMC Health Services Research, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Health Services Research
BMC Health Services Research, 21(1):611. BioMed Central Ltd.
BMC Health Services Research, 21:611. BMC
Background The causes and consequences of childhood obesity are complex and multifaceted. Therefore, an integrated care approach is required to address weight-related issues and improve children’s health, societal participation and quality of life.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ad697bb708ba49f933458ee5c03eec
https://doaj.org/article/dedd138ef8514fb4bb398b13c256b2b9
Zobrazit plný text záznamu
8
Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital
Autor: Gemma Navarro, M. Cervantes, Oriol Gasch, Aina Gomila, M L Machado, E Prieto, E Van den Eynde, J Oristrell, J C Oliva, L Falgueras, S Calzado, S Ortonobes, A Morón, Silvia Capilla, M. Navarro
Publikováno v: Infectious Diseases (London, England)
article-version (VoR) Version of Record
Background There is an urgent need to reduce mortality of COVID-19. We examined if corticosteroids and tocilizumab reduce risk for death in patients with severe pneumonia caused by SARS-CoV-2. Methods A retrospective cohort study was performed in a s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b11a77a4d581afc30774e203c528d8
https://doi.org/10.1080/23744235.2021.1884286
Zobrazit plný text záznamu
9
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study
Autor: D. Podzamczer, N. Rozas, P. Domingo, C. Miralles, E. Van den Eynde, A. Romero, E. Deig, H. Knobel, J. Pasquau, A. Antela, B. Clotet, P. Geijo, E. Rodríguez de Castro, M.A. Casado, A. Muñoz, A. Casado, null for the PRO-STR STUDY GROUP
Publikováno v: Current HIV Research
Background: To investigate the impact of switching from stable Combined Antiretroviral Therapy (cART) to single-tablet regimen (RPV/FTC/TDF=EVIPLERA® /COMPLERA®) on patient-reported outcomes in HIV-infected adults who cannot tolerate previous cART,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f7ffdd28096993a73e71fc3086bc18e
https://doi.org/10.2174/1570162x17666190212163518
Zobrazit plný text záznamu
10
[Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients]
Autor: I Torrente Jiménez, M Gómez-Valent, E Van den Eynde Otero, N Soler-Blanco, S Ortonobes Roig, Marc Moreno-Ariño
Publikováno v: Revista Española de Quimioterapia
Introduction. Despite the impact of SARS-CoV-2 infection in geriatrics, data on nonagenarian patients is scarce. The aim of this study is to describe the clinical features of COVID19-diagnosed nonagenarians, as well as its clinical evolution and ther
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24a80e73fbedc75931eed0aa6ae9ce0
https://pubmed.ncbi.nlm.nih.gov/33522213
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje